Mary Cohen-Williams

1.2k total citations
28 papers, 892 citations indexed

About

Mary Cohen-Williams is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Mary Cohen-Williams has authored 28 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in Mary Cohen-Williams's work include Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Adenosine and Purinergic Signaling (7 papers). Mary Cohen-Williams is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Adenosine and Purinergic Signaling (7 papers). Mary Cohen-Williams collaborates with scholars based in United States, Bulgaria and Switzerland. Mary Cohen-Williams's co-authors include Geoffrey B. Varty, Vicki L. Coffin, John C. Hunter, Galen Carey, Jean E. Lachowicz, Robert A. Hodgson, Guy A. Higgins, Constance Farley, Timothy J. Kowalski and Brian D. Spar and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mary Cohen-Williams

28 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Cohen-Williams United States 17 445 441 153 136 131 28 892
Philip A. Iredale United States 18 511 1.1× 464 1.1× 95 0.6× 95 0.7× 84 0.6× 30 1.1k
Karen Benwell United Kingdom 13 493 1.1× 401 0.9× 55 0.4× 104 0.8× 120 0.9× 16 909
Marcos Emílio Frizzo Brazil 18 595 1.3× 495 1.1× 276 1.8× 154 1.1× 31 0.2× 31 1.2k
Silva Fredduzzi Italy 12 470 1.1× 263 0.6× 216 1.4× 189 1.4× 44 0.3× 13 848
Victor I. Ilyin United States 22 481 1.1× 699 1.6× 71 0.5× 173 1.3× 141 1.1× 35 1.1k
Michael A. Ackley United States 13 401 0.9× 287 0.7× 207 1.4× 152 1.1× 29 0.2× 22 859
Kathy L. Kohlhaas United States 19 290 0.7× 674 1.5× 97 0.6× 244 1.8× 222 1.7× 33 1.2k
Jens Nagel Germany 18 490 1.1× 328 0.7× 169 1.1× 77 0.6× 32 0.2× 33 805
Takeo Oshima Japan 9 780 1.8× 571 1.3× 37 0.2× 113 0.8× 44 0.3× 15 1.2k
Dorota Łażewska Poland 24 178 0.4× 746 1.7× 67 0.4× 125 0.9× 305 2.3× 86 1.4k

Countries citing papers authored by Mary Cohen-Williams

Since Specialization
Citations

This map shows the geographic impact of Mary Cohen-Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Cohen-Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Cohen-Williams more than expected).

Fields of papers citing papers by Mary Cohen-Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Cohen-Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Cohen-Williams. The network helps show where Mary Cohen-Williams may publish in the future.

Co-authorship network of co-authors of Mary Cohen-Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Cohen-Williams. A scholar is included among the top collaborators of Mary Cohen-Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Cohen-Williams. Mary Cohen-Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wen‐Lian, Duane A. Burnett, John W. Clader, et al.. (2016). Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5836–5841. 2 indexed citations
2.
Qin, Jun, Wei Zhou, Xianhai Huang, et al.. (2011). Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators. ACS Medicinal Chemistry Letters. 2(6). 471–476. 22 indexed citations
3.
Qin, Jun, Xianhai Huang, Mihirbaran Mandal, et al.. (2010). Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 21(2). 664–669. 19 indexed citations
4.
Hodgson, Robert A., Lynn A. Hyde, Mary Cohen-Williams, et al.. (2010). Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination. Pharmacology Biochemistry and Behavior. 98(2). 181–187. 13 indexed citations
5.
Caldwell, John P., Robert Mazzola, Thomas Bara, et al.. (2010). Iminoheterocycles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 20(18). 5380–5384. 19 indexed citations
6.
7.
Varty, Geoffrey B., Sherry Lu, Cynthia A. Morgan, et al.. (2008). The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). Journal of Pharmacology and Experimental Therapeutics. 326(2). 672–682. 67 indexed citations
8.
Chackalamannil, Samuel, William J. Greenlee, Bernard R. Neustadt, et al.. (2008). Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(14). 4204–4209. 16 indexed citations
9.
Neustadt, Bernard R., Hong Liu, Jinsong Hao, et al.. (2008). Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines. Bioorganic & Medicinal Chemistry Letters. 19(3). 967–971. 34 indexed citations
10.
Matasi, Julius J., John P. Caldwell, Hongtao Zhang, et al.. (2006). 2‐(2‐Furanyl)‐7‐phenyl[1,2,4]triazolo[1,5‐c]pyrimidin‐5‐amine Analogues: Highly Potent, Orally Active, Adenosine A2A Antagonists. Part 1.. ChemInform. 37(4). 3 indexed citations
11.
Matasi, Julius J., John P. Caldwell, Hongtao Zhang, et al.. (2005). 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A2A antagonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 15(16). 3670–3674. 15 indexed citations
12.
Matasi, Julius J., John P. Caldwell, Hongtao Zhang, et al.. (2005). 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: The successful reduction of hERG activity. Part 2. Bioorganic & Medicinal Chemistry Letters. 15(16). 3675–3678. 15 indexed citations
13.
Kowalski, Timothy J., Constance Farley, Mary Cohen-Williams, Geoffrey B. Varty, & Brian D. Spar. (2004). Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size. European Journal of Pharmacology. 497(1). 41–47. 68 indexed citations
14.
Varty, Geoffrey B., Mary Cohen-Williams, & John C. Hunter. (2003). The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behavioural Pharmacology. 14(1). 87–95. 59 indexed citations
15.
Duffy, Ruth A., Joseph A. Hedrick, Cynthia A. Morgan, et al.. (2003). Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology. 45(2). 242–250. 71 indexed citations
16.
Varty, Geoffrey B., et al.. (2001). Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. European Journal of Pharmacology. 424(1). 27–36. 58 indexed citations
17.
Carey, Galen, William Billard, Herbert Binch, et al.. (2001). SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. European Journal of Pharmacology. 431(2). 189–200. 59 indexed citations
18.
Lachowicz, Jean E., Ruth A. Duffy, Vilma Ruperto, et al.. (2001). Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sciences. 68(22-23). 2585–2592. 32 indexed citations
19.
Cohen-Williams, Mary, et al.. (1996). Cholinergic improvement of a naturally-occurring memory deficit in the young rat. Brain Research. 707(1). 13–21. 39 indexed citations
20.
Coffin, Vicki L., Mary Cohen-Williams, & Allen Barnett. (1994). Selective antagonism of the anticonvulsant effects of felbamate by glycine. European Journal of Pharmacology. 256(2). R9–R10. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip A. Iredale Breakdown of academic impact, for papers by Karen Benwell Breakdown of academic impact, for papers by Marcos Emílio Frizzo Breakdown of academic impact, for papers by Silva Fredduzzi Breakdown of academic impact, for papers by Victor I. Ilyin Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Kathy L. Kohlhaas Breakdown of academic impact, for papers by Jens Nagel Breakdown of academic impact, for papers by Takeo Oshima Breakdown of academic impact, for papers by Dorota Łażewska
Rankless by CCL
2026